The Team

Founded in 2020, through the acquisition of the Drug Discovery & Preclinical Development center from Esteve Pharmaceuticals S.A., Welab Barcelona is formed by experienced scientists with a proven track record across the entire drug discovery and development cycle, successfully translating new discoveries into clinical PoC. The team has an extensive network of past and present collaborations with universities, research centers, SMEs, and pharmaceutical companies, either through one-to-one collaborations or through both Spanish and European founded public-private partnerships. The leadership team is experienced in engaging with multiple regulatory authorities, including EMA, FDA, MHRA, BfArM, AEMPS, etc.

Academic Excellence and Research Dissemination

Our team boasts a diverse range of academic achievements, with 51% of our members holding PhDs. This academic diversity fosters a dynamic blend of expertise, enabling us to tackle complex challenges from multiple angles.

Our extensive list of publications and patents demonstrates our commitment to pushing the boundaries of pharmaceutical research and our contribution to the broader scientific community.

Guidance and Leadership in Drug Discovery and Development

We pride ourselves on being trusted guides on your drug discovery and development journey. Leveraging our collective experience, we offer strategic insights and leadership to navigate the intricacies of the pharmaceutical landscape.

Cutting-Edge Research and Timely Delivery

Our team possesses not only the scientific knowledge but also the technological capabilities required to conduct experiments with precision and efficiency. We adhere to the highest standards of quality, ensuring that our research is conducted in the most effective manner and delivered on time. In addition, some of our services a GLP-certified.

At Welab, we are dedicated to making a difference in the pharmaceutical industry. Join us on our quest to innovate, discover, and develop solutions that have the potential to transform lives.


Leadership Team

Silvia García

Toxicology Head


The R&D Site

Our R&D site is the largest integrated Drug Discovery Center in Spain, a first level infrastructure provided with cutting-edge equipment and technologies. Welab has 2,331 m2  dedicated space to research laboratories. It is located in the Science Park of Barcelona, one of the biggest innovation hubs in Spain. Moreover, the life sciences and healthcare ecosystem in Catalonia is one of the most active ones in southern Europe, according to the report “The life sciences and healthcare sector in Catalonia – 2022 BioRegion Report”.

Our commitment to sustainability and environmental care is at the core of our operations, so we take on every step to minimize our ecological footprint. In this respect:

    • We have implemented a closed water circuit for our lab evaporators, significantly reducing water consumption.
    • Our hoods are equipped with presence sensors, intelligently regulating energy usage, contributing to lower energy consumption.
    • Waste management is a top priority; we meticulously segregate solvents during disposal, enabling solvent recovery, thus reducing waste.
    • We have established a robust selective collection system for various waste types.
    • We have embraced a paperless environment and adopted electronic notebooks, significantly cutting down on paper and ink consumption.

Dear colleagues, collaborators, and friends,

After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team.

We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients.

As we bid farewell, let’s cherish the memories we’ve created, the bonds we’ve formed, and the impact we’ve made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure.

We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges.

With heartfelt appreciation,

Welab’s team

We are proud to announce that Welab is partner of this new EU funded project.

In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS